Maren Meiboom
Publications by Year
Research Areas
Thyroid Cancer Diagnosis and Treatment, Estrogen and related hormone effects, Peroxisome Proliferator-Activated Receptors, Genetic and Clinical Aspects of Sex Determination and Chromosomal Abnormalities, Advanced Glycation End Products research
Most-Cited Works
- Variation of HMGB1 expression in breast cancer.(2002)
- → Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas(2003)72 cited
- → A KRAB zinc finger protein gene is the potential target of 19q13 translocation in benign thyroid tumors(1999)54 cited
- → Chromogenic in situ hybridization is a reliable assay for detection of ALK rearrangements in adenocarcinomas of the lung(2013)37 cited
- → Evidence for a 3p25 Breakpoint Hot Spot Region in Thyroid Tumors of Follicular Origin(2006)27 cited
- → Chromogenic in situ Hybridization is a Reliable Alternative to Fluorescence in situ Hybridization for Diagnostic Testing of 1p and 19q Loss in Paraffin‐Embedded Gliomas(2012)25 cited
- → Delineation of a 150-kb breakpoint cluster in benign thyroid tumors with 19q13.4 aberrations(2001)19 cited
- → A 3.4-kbp transcript of ZNF331 is solely expressed in follicular thyroid adenomas(2003)17 cited
- → Does conventional cytogenetics detect the real frequency of 19q13 aberrations in benign thyroid lesions? A survey of 38 cases(2003)4 cited